New heterobifunctional cross-linking reagents for protein conjugation, N-(bromoacetamido-n-alkanoyloxy)succinimides.

DOI: 10.1248/cpb.35.1991

Source and publish data:

Chemical and pharmaceutical bulletin p. 1991 - 1997 (1987)

Update date:2022-08-04

Topics:

Authors:

Zaitsu Zaitsu

Ohnishi Ohnishi

Hosoya Hosoya

Sugimoto

Ohkura Ohkura

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.35.1991

Full text of DOI:10.1248/cpb.35.1991

Products guided by the article

Product name:Succinimidyl-4-(bromoacetamido)butanoate

Cas No:95413-05-1

R&D Labs maybe for 95413-05-1

WUXI KINGHAN BIO-MEDICAL&CHEMICAL INC.

Contact:13861062998

Address:Room 1316,No.1619 Huishan Avenue,Wuxi,China
Zhejiang Newfine Industry Co.,Ltd.

Contact:+86-573-82262042

Address:No.225,Dongqing Road, garoms@163.com
Zibo Ocean International Trade Co.,Ltd(expird)

Contact:+86 533 5160706

Address:1117, Hongtai Bld., Songling rd, Zichuan,Zibo,Shandong,China
shanghai Tauto Biotech Co., Ltd

website:http://www.tautobiotech.com/en/index.htm

Contact:+86-21-51320588 ext. 8025

Address:No. 326, Aidisheng Rd , Zhangjiang Hi-tech Park, Shanghai , P.R.CHINA
Changzhou Kingyo Chemical Corporation Ltd.

website:http://www.kingyochem.com

Contact:+86-519-85105717

Address:19# Wuqing North Road, Changzhou , Jiangsu, China

Relevant to this article

Doi:10.1021/ja01193a036
(1947)
Reaction of 2-Bromo-1,4-dimethoxybenzene with Various Nucleophiles via Aryne Reaction

Doi:10.1021/jo00208a048
(1985)
Toward total spontaneous resolution of sec-Butylzinc complexes

Doi:10.1021/om9007828
(2010)
Discovery of a potent protein kinase D inhibitor: insights in the binding mode of pyrazolo[3,4-d]pyrimidine analogues

Doi:10.1039/c6md00675b
(2017)
Thieno[1,3,2]oxazaborinine-containing aza-BODIPYs with near infrared absorption bands: Synthesis, photophysical properties, and device applications

Doi:10.1039/c9nj04612g
(2020)
Synthesis and the interaction of 2-(1H-pyrazol-4-yl)-1H-imidazo[4,5-f][1,10]phenanthrolines with telomeric DNA as lung cancer inhibitors

Doi:10.1016/j.ejmech.2017.03.030
(2017)

Article Doi